ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Tinofend Extract

Also known as: Guduchi, Giloy, Heart-leaved moonseed, Tinofend Extract, Tinospora cordifolia

Overview

Tinospora cordifolia, commonly known as Guduchi or Giloy, is a climbing shrub native to India and a staple in Ayurvedic medicine. It is traditionally valued for its immune-modulating, anti-inflammatory, and antioxidant properties. Tinofend Extract is a branded, standardized aqueous extract of Tinospora cordifolia, specifically studied for its potential benefits in allergic rhinitis and cognitive vitality. While it is used for various conditions including diabetes and general immune support, the overall research maturity is characterized by a dominance of preclinical studies and small clinical trials, with a limited number of high-quality randomized controlled trials (RCTs) and no large-scale meta-analyses specifically on Tinofend Extract. The evidence quality is considered moderate to low, necessitating further robust research.

Benefits

Tinofend Extract shows promise in several areas, though the strength of evidence varies. One double-blind randomized controlled trial indicated that Tinofend (150 or 300 mg aqueous extract) significantly improved mean maximum speed (a proxy for cognitive/physical performance) and reduced systolic blood pressure and heart rate during fixed workload exercise in individuals with allergic rhinitis, suggesting a benefit for this condition. In preclinical settings, Tinospora cordifolia extracts have demonstrated significant antimicrobial effects against oral pathogens like Streptococcus mutans and Candida albicans, comparable to chlorhexidine in vitro. Furthermore, in various cancer cell lines (colon, breast, neuroblastoma, oral squamous carcinoma), preclinical studies showed inhibition of proliferation and induction of apoptosis. There is also limited evidence suggesting potential for improving blood sugar control in type 2 diabetes, though this requires further confirmation through clinical trials.

How it works

The mechanisms of action for Tinospora cordifolia are multifaceted. It exerts antioxidant and anti-inflammatory effects by modulating immune responses and reducing oxidative stress within the body. In cancer models, it has been shown to induce apoptosis (programmed cell death) and autophagy in cancer cells, primarily through mitochondrial pathways and an increase in reactive oxygen species (ROS). Its antimicrobial activity is attributed to various bioactive phytochemicals that inhibit the growth of bacteria and fungi. Additionally, in the context of exercise, it may modulate cardiovascular parameters such as blood pressure and heart rate, contributing to improved performance.

Side effects

Tinofend Extract is generally considered safe for short-term oral use at studied doses (150-300 mg aqueous extract). The most commonly reported adverse events, occurring in more than 5% of users, include headache and nasal pain. However, there are rare but serious adverse events reported, specifically cases of acute liver injury or hepatitis linked to Tinospora cordifolia use. These cases highlight the need for caution, especially with prolonged or high-dose intake, and suggest that individuals with pre-existing liver conditions or those taking hepatotoxic drugs should exercise extreme caution and seek medical advice. Drug interactions are not well characterized, and safety in special populations such as pregnant or lactating women and children has not been established due to limited data.

Dosage

Clinical studies investigating Tinofend Extract have typically utilized daily dosages ranging from 150 mg to 300 mg of the aqueous extract. These dosages have demonstrated both efficacy and general tolerability in short-term use. There is currently no established maximum safe dose for Tinospora cordifolia, and due to rare reports of liver toxicity, caution is advised, particularly with higher or prolonged intake. The supplement is typically administered orally as a standardized aqueous extract. Information regarding the absorption and bioavailability of Tinofend Extract is limited, but aqueous extracts are the common form used in clinical research.

FAQs

Is Tinofend Extract safe?

Generally, Tinofend Extract is considered safe for short-term use at studied doses. However, users should monitor for common side effects like headache or nasal discomfort. Rare cases of liver injury have been reported, warranting caution.

What conditions does it help?

Evidence is strongest for its potential benefits in allergic rhinitis. Preclinical studies also show antimicrobial and anticancer effects, and there's limited evidence for metabolic benefits, such as blood sugar control.

How soon do benefits appear?

Some clinical trials have observed benefits within 14 to 28 days of consistent use, particularly for conditions like allergic rhinitis.

Can it replace conventional treatments?

No, Tinofend Extract should not replace conventional medical treatments. It is best considered a complementary supplement and should be used under medical supervision.

Research Sources

  • https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Tinospora-cordifolia-Cognitive-Vitality-For-Researchers.pdf – This source provides an overview of Tinospora cordifolia, including its traditional uses and a summary of a double-blind RCT on Tinofend Extract for allergic rhinitis. The RCT showed significant improvements in exercise parameters and cardiovascular markers, but noted limitations due to small sample size and short duration. It also discusses preclinical findings on cancer models and the general safety profile.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC10112095/ – This in vitro study investigated the antimicrobial activity of Tinospora cordifolia extracts against Streptococcus mutans and Candida albicans. It demonstrated significant zones of inhibition, comparable or superior to chlorhexidine, suggesting potential as an antimicrobial agent. However, it lacks clinical trial data on antimicrobial efficacy in humans.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC10238282/ – This source presents a case report and review concerning Tinospora cordifolia-induced liver injury. It highlights the rare but serious potential for hepatotoxicity associated with the supplement, emphasizing the need for caution and further research, especially regarding safety in individuals with liver conditions.
  • https://www.webmd.com/vitamins/ai/ingredientmono-1157/tinospora-cordifolia – This WebMD article provides a general overview of Tinospora cordifolia, including its common names, traditional uses, and potential benefits. It also touches upon its safety profile, noting that while generally well-tolerated, caution is advised due to limited high-quality evidence and potential side effects.
  • https://jrasb.com/index.php/jrasb/article/view/665 – This source discusses preclinical studies on Tinospora cordifolia's effects in cancer models. It details how extracts inhibited proliferation and induced apoptosis in various cancer cell lines through mitochondrial pathways, ROS generation, and cell cycle arrest, indicating potential anticancer properties in vitro.

Supplements Containing Tinofend Extract

Defense by Reliv
83

Defense

Reliv

Score: 83/100